Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
Bi121
COVID-19
Neoilludin B
Pelargonium sidoides
SARS-CoV-2
antiviral
intercalating agent
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 05 2023
31 05 2023
Historique:
received:
20
04
2023
revised:
12
05
2023
accepted:
24
05
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has so far infected 762 million people with over 6.9 million deaths worldwide. Broad-spectrum viral inhibitors that block the initial stages of infection by reducing virus binding and proliferation, thereby reducing disease severities, are still an unmet global medical need. We studied Bi121, which is a standardized polyphenolic-rich compound isolated from
Identifiants
pubmed: 37376598
pii: v15061299
doi: 10.3390/v15061299
pmc: PMC10305169
pii:
doi:
Substances chimiques
Antiviral Agents
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nucleic Acids Res. 2017 Jul 3;45(W1):W356-W360
pubmed: 28472422
Vet Med Sci. 2021 Mar;7(2):559-571
pubmed: 33210477
Nucleic Acids Res. 2005 Oct 19;33(18):5887-95
pubmed: 16237124
Front Chem. 2022 Oct 06;10:948553
pubmed: 36353143
Curr Top Med Chem. 2008;8(18):1555-72
pubmed: 19075767
Bioinformatics. 2013 Jul 15;29(14):1827-9
pubmed: 23712658
Phytomedicine. 2007;14 Suppl 6:9-17
pubmed: 17188477
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
Eur J Pediatr. 2021 Sep;180(9):3019-3028
pubmed: 34304301
J Med Chem. 2008 Aug 28;51(16):5043-51
pubmed: 18680273
AAPS J. 2013 Apr;15(2):395-406
pubmed: 23292636
J Autoimmun. 2022 Jan;126:102779
pubmed: 34915422
J Am Chem Soc. 2004 Dec 29;126(51):16718-9
pubmed: 15612698
Phytomedicine. 2008 Dec;15(12):1108-16
pubmed: 18691858
Drug Discov Today. 2022 Jul;27(7):1785-1788
pubmed: 35661705
Antiviral Res. 2011 Jan;89(1):9-18
pubmed: 21070811
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292871
Biochem Biophys Res Commun. 2021 Jan 29;538:88-91
pubmed: 33199021
Ther Adv Infect Dis. 2023 Apr 20;10:20499361231168520
pubmed: 37101696
N Engl J Med. 2022 Feb 10;386(6):509-520
pubmed: 34914868
Drug Discov Today. 2022 Jul;27(7):1954-1960
pubmed: 35192924
Infect Disord Drug Targets. 2023 May 09;:
pubmed: 37165585
J Chem Inf Model. 2011 Mar 28;51(3):624-34
pubmed: 21361385
Phytomedicine. 2003;10 Suppl 4:7-17
pubmed: 12807337
N Engl J Med. 2022 Jan 27;386(4):305-315
pubmed: 34937145
Int J Gen Med. 2018 Mar 08;11:91-98
pubmed: 29563828
BMC Genomics. 2017 Mar 14;18(Suppl 2):114
pubmed: 28361695
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
J Phys Chem B. 2020 Aug 13;124(32):6955-6962
pubmed: 32521159
J Ethnopharmacol. 2008 Oct 28;119(3):420-33
pubmed: 18725280
Virology. 2020 Sep;548:39-48
pubmed: 32838945
RSC Adv. 2023 Jan 26;13(6):3677-3687
pubmed: 36756584
PLoS One. 2014 Jan 29;9(1):e87487
pubmed: 24489923
Lancet Infect Dis. 2023 Jun;23(6):655-656
pubmed: 37148902
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Biochem Pharmacol. 1994 Jul 19;48(2):403-9
pubmed: 8053936
Front Pharmacol. 2021 Oct 25;12:757666
pubmed: 34759825
Phytomedicine. 2011 Mar 15;18(5):384-6
pubmed: 21036571
J Nat Prod. 2003 Sep;66(9):1257-8
pubmed: 14510611
Nucleic Acids Res. 2017 Jan 4;45(D1):D271-D281
pubmed: 27794042
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20
pubmed: 34611326
Hepatology. 2017 Apr;65(4):1104-1116
pubmed: 27863453
J Virol Methods. 2010 Nov;169(2):365-74
pubmed: 20709108
Antiviral Res. 2012 May;94(2):147-56
pubmed: 22475498
Chemistry. 2019 Sep 25;25(54):12644-12651
pubmed: 31310394